bluebird bio, Inc. Quarterly Operating Income (Loss) in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
bluebird bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2012 to Q1 2024.
  • bluebird bio, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$78.7M, a 832% decline year-over-year.
  • bluebird bio, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$334M, a 180% decline year-over-year.
  • bluebird bio, Inc. annual Operating Income (Loss) for 2023 was -$244M, a 2.37% increase from 2022.
  • bluebird bio, Inc. annual Operating Income (Loss) for 2022 was -$250M, a 57.7% increase from 2021.
  • bluebird bio, Inc. annual Operating Income (Loss) for 2021 was -$591M, a 5.66% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$334M -$78.7M -$89.4M -832% Jan 1, 2024 Mar 31, 2024 10-Q 2024-09-13
Q4 2023 -$244M -$85M -$147M -236% Oct 1, 2023 Dec 31, 2023 10-K 2024-09-13
Q3 2023 -$96.9M -$84.7M +$52K +0.06% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$97M -$85.3M +$22.1M +20.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$119M $10.7M +$131M Jan 1, 2023 Mar 31, 2023 10-Q 2024-09-13
Q4 2022 -$250M $62.3M +$198M Oct 1, 2022 Dec 31, 2022 10-K 2024-09-13
Q3 2022 -$448M -$84.8M +$69.7M +45.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$518M -$107M +$47.3M +30.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$565M -$120M +$25.7M +17.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$591M -$136M +$3.72M +2.67% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-04
Q3 2021 -$595M -$154M -$22.7M -17.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$572M -$155M -$11.1M -7.69% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$561M -$146M -$1.62M -1.12% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$559M -$139M +$91.1M +39.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-04
Q3 2020 -$650M -$132M +$78.7M +37.4% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-04
Q2 2020 -$729M -$144M +$59.1M +29.1% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-04
Q1 2020 -$788M -$144M +$26.7M +15.6% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-04
Q4 2019 -$815M -$231M -$73.6M -46.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-23
Q3 2019 -$741M -$210M -$60.6M -40.4% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-23
Q2 2019 -$681M -$203M -$54.1M -36.4% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-23
Q1 2019 -$627M -$171M -$54.5M -46.8% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-23
Q4 2018 -$572M -$157M -$40.2M -34.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-18
Q3 2018 -$532M -$150M -$72.2M -92.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-18
Q2 2018 -$460M -$149M -$80.8M -119% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-18
Q1 2018 -$379M -$117M -$46.7M -66.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-18
Q4 2017 -$332M -$117M -$44.4M -61.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q3 2017 -$288M -$77.7M +$482K +0.62% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-21
Q2 2017 -$288M -$67.8M -$7.85M -13.1% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-21
Q1 2017 -$280M -$69.9M -$12.5M -21.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-21
Q4 2016 -$268M -$72.3M -$23.4M -47.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-21
Q3 2016 -$244M -$78.1M -$35M -81.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-21
Q2 2016 -$209M -$60M -$7.95M -15.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-21
Q1 2016 -$201M -$57.4M -$32.5M -130% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-21
Q4 2015 -$169M -$49M -$29.3M -150% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-22
Q3 2015 -$140M -$43.1M -$26.1M -154% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-22
Q2 2015 -$114M -$52M -$38.7M -290% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-22
Q1 2015 -$74.9M -$24.9M -$14.3M -134% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-22
Q4 2014 -$60.6M -$19.6M -$11.5M -142% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-25
Q3 2014 -$49.1M -$17M -$10.9M -176% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 -$38.3M -$13.3M -$9.14M -218% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 -$29.1M -$10.7M -$4.19M -64.6% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25
Q4 2013 -$24.9M -$8.12M +$841K +9.39% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-25
Q3 2013 -$25.8M -$6.16M -$1.13M -22.6% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-25
Q2 2013 -$24.7M -$4.19M +$406K +8.83% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-25
Q1 2013 -$25.1M -$6.48M -$1.35M -26.2% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-25
Q4 2012 -$23.7M -$8.96M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-05
Q3 2012 -$5.02M Jul 1, 2012 Sep 30, 2012 10-K 2014-03-05
Q2 2012 -$4.6M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-05
Q1 2012 -$5.14M Jan 1, 2012 Mar 31, 2012 10-K 2014-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.